These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22098712)

  • 1. Insulin resistance increases the occurrence of new cardiovascular events in patients with manifest arterial disease without known diabetes. the SMART study.
    Verhagen SN; Wassink AM; van der Graaf Y; Gorter PM; Visseren FL;
    Cardiovasc Diabetol; 2011 Nov; 10():100. PubMed ID: 22098712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance and systemic inflammation, but not metabolic syndrome phenotype, predict 9 years mortality in older adults.
    Zuliani G; Morieri ML; Volpato S; Maggio M; Cherubini A; Francesconi D; Bandinelli S; Paolisso G; Guralnik JM; Ferrucci L
    Atherosclerosis; 2014 Aug; 235(2):538-45. PubMed ID: 24956526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance is associated with increased risk of major cardiovascular events in patients with preexisting coronary artery disease.
    Tenenbaum A; Adler Y; Boyko V; Tenenbaum H; Fisman EZ; Tanne D; Lapidot M; Schwammenthal E; Feinberg MS; Matas Z; Motro M; Behar S
    Am Heart J; 2007 Apr; 153(4):559-65. PubMed ID: 17383294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome and risk of incident heart failure in non-diabetic patients with established cardiovascular disease.
    Burger PM; Koudstaal S; Dorresteijn JAN; Savarese G; van der Meer MG; de Borst GJ; Mosterd A; Visseren FLJ;
    Int J Cardiol; 2023 May; 379():66-75. PubMed ID: 36907452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study.
    Rutter MK; Meigs JB; Sullivan LM; D'Agostino RB; Wilson PW
    Diabetes; 2005 Nov; 54(11):3252-7. PubMed ID: 16249452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homeostasis Model Assessment of Insulin Resistance and Survival in Patients With Diabetes and Acute Coronary Syndrome.
    Stähli BE; Nozza A; Schrieks IC; Buse JB; Malmberg K; Mellbin L; Neal B; Nicholls SJ; Rydén L; Svensson A; Wedel H; Weichert A; Lincoff AM; Grobbee DE; Tardif JC; Schwartz GG
    J Clin Endocrinol Metab; 2018 Jul; 103(7):2522-2533. PubMed ID: 29659887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients.
    Vlek AL; van der Graaf Y; Spiering W; Visseren FL;
    J Hum Hypertens; 2008 May; 22(5):358-65. PubMed ID: 18273039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease.
    Shinohara K; Shoji T; Emoto M; Tahara H; Koyama H; Ishimura E; Miki T; Tabata T; Nishizawa Y
    J Am Soc Nephrol; 2002 Jul; 13(7):1894-900. PubMed ID: 12089386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance and chronic kidney disease progression, cardiovascular events, and death: findings from the chronic renal insufficiency cohort study.
    Schrauben SJ; Jepson C; Hsu JY; Wilson FP; Zhang X; Lash JP; Robinson BM; Townsend RR; Chen J; Fogelfeld L; Kao P; Landis JR; Rader DJ; Hamm LL; Anderson AH; Feldman HI
    BMC Nephrol; 2019 Feb; 20(1):60. PubMed ID: 30786864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolic syndrome in elderly individuals is associated with greater muscular, but not elastic arterial stiffness, independent of low-grade inflammation, endothelial dysfunction or insulin resistance--The Hoorn Study.
    Henry RM; Ferreira I; Dekker JM; Nijpels G; Scheffer PG; Stehouwer CD
    J Hum Hypertens; 2009 Nov; 23(11):718-27. PubMed ID: 19279658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary creatinine excretion, an indirect measure of muscle mass, is an independent predictor of cardiovascular disease and mortality in the general population.
    Oterdoom LH; Gansevoort RT; Schouten JP; de Jong PE; Gans RO; Bakker SJ
    Atherosclerosis; 2009 Dec; 207(2):534-40. PubMed ID: 19535078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort.
    Guembe MJ; Fernandez-Lazaro CI; Sayon-Orea C; Toledo E; Moreno-Iribas C;
    Cardiovasc Diabetol; 2020 Nov; 19(1):195. PubMed ID: 33222691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of different metabolic syndrome definitions and risks of incident cardiovascular events in the elderly.
    Vinluan CM; Zreikat HH; Levy JR; Cheang KI
    Metabolism; 2012 Mar; 61(3):302-9. PubMed ID: 21840552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of systemic inflammation on the relationship between insulin resistance and all-cause and cancer-related mortality.
    Lee DY; Rhee EJ; Chang Y; Sohn CI; Shin HC; Ryu S; Lee WY
    Metabolism; 2018 Apr; 81():52-62. PubMed ID: 29191456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance as a predictor of cardiovascular disease in patients on peritoneal dialysis.
    Li Y; Zhang L; Gu Y; Hao C; Zhu T
    Perit Dial Int; 2013; 33(4):411-8. PubMed ID: 23455976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic Kidney Disease in Non-Diabetic Older Adults: Associated Roles of the Metabolic Syndrome, Inflammation, and Insulin Resistance.
    Zammit AR; Katz MJ; Derby C; Bitzer M; Lipton RB
    PLoS One; 2015; 10(10):e0139369. PubMed ID: 26431218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homeostasis model assessment of insulin resistance and the risk of cardiovascular events in middle-aged non-diabetic Japanese men.
    Nakamura K; Sakurai M; Miura K; Morikawa Y; Ishizaki M; Yoshita K; Kido T; Naruse Y; Nakagawa H
    Diabetologia; 2010 Sep; 53(9):1894-902. PubMed ID: 20502862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin resistance and risk of vascular events, interventions and mortality in type 1 diabetes.
    Helmink MAG; de Vries M; Visseren FLJ; de Ranitz WL; de Valk HW; Westerink J
    Eur J Endocrinol; 2021 Nov; 185(6):831-840. PubMed ID: 34636745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased insulin resistance and risk of incident cerebrovascular events in patients with pre-existing atherothrombotic disease.
    Tanne D; Tenenbaum A; Boyko V; Benderly M; Fisman EZ; Matas Z; Adler Y; Behar S
    Eur J Neurol; 2009 Nov; 16(11):1217-23. PubMed ID: 19538221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation between thyroid-stimulating hormone and the occurrence of cardiovascular events and mortality in patients with manifest vascular diseases.
    Westerink J; van der Graaf Y; Faber DR; Spiering W; Visseren FL;
    Eur J Prev Cardiol; 2012 Aug; 19(4):864-73. PubMed ID: 21724680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.